Treatment of ADCY5 -Associated Dystonia, Chorea, and Hyperkinetic Disorders with Deep Brain Stimulation

Journal of Child Neurology

Volumn 31, Issue 8, 2016, Pages 1027-1035

  Dy, Marisela E ^a,b,c   Chang, Florence C F ^d,e   Jesus, Sol De ^f   Anselm, Irina ^a,c   Mahant, Neil ^d,e   Zeilman, Pamela ^f   Rodan, Lance H ^a,c   Foote, Kelly D ^f   Tan, Wen Hann ^b,c   Eskandar, Emad ^c   Sharma, Nutan ^a,b,c   Okun, Michael S ^f   Fung, Victor S C ^d,e   Waugh, Jeff L ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WESTMEAD HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

ADCY5; chorea; deep brain stimulation; hyperkinetic movements; whole exome sequencing

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE 5; AMANTADINE; BOTULINUM ANTISERUM; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CHLORAL HYDRATE; CLONAZEPAM; DIAZEPAM; HALOPERIDOL; LEVODOPA; LORAZEPAM; PHENOBARBITAL; PROPRANOLOL; TETRABENAZINE; TRAZODONE; UNCLASSIFIED DRUG; VALPROIC ACID; ZOLPIDEM; ADENYLYL CYCLASE TYPE V;

ADENYLYL CYCLASE 5 GENE; ADULT; ARTICLE; AUTOMUTILATION; BOTULISM; BRAIN DEPTH STIMULATION; CASE REPORT; CEREBRAL PALSY; CHILD; CHOREA; CHOREOATHETOSIS; CURRENT DENSITY; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DONOR SITE; DYSTONIA; ENERGY EXPENDITURE; FAILURE TO THRIVE; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; GLOBUS PALLIDUS; HEAD CIRCUMFERENCE; HUMAN; HYPERKINESIA; HYPERREFLEXIA; LANGUAGE DELAY; MALE; MUSCLE BIOPSY; MUSCLE HYPOTONIA; PERIODIC LIMB MOVEMENT DISORDER; PHYSIOTHERAPY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP DISORDER; SPASTICITY; STARTLE REFLEX; WEIGHT GAIN; CLINICAL TRIAL; DYSTONIC DISORDER; ENZYMOLOGY; GENETICS; MULTICENTER STUDY; MUTATION; PHENOTYPE;

ADENYLYL CYCLASES; ADULT; CHILD; CHILD, PRESCHOOL; CHOREA; DEEP BRAIN STIMULATION; DYSTONIC DISORDERS; FEMALE; HUMANS; HYPERKINESIS; MALE; MUTATION; PHENOTYPE;

EID: 84974691584     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073816635749     Document Type: Article

References (18)

1. Shaw C, Hisama F, Friedman J, Bird TD,. ADCY5 -related dyskinesia. December 18, 2014. Updated December 17, 2015. In: Pagon RA, Adam MP, Ardinger HH, et al.eds. GeneReviews®. Seattle: University of Washington; 1993-2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK263441/.
2. Wild EJ, Tabrizi SJ,. The differential diagnosis of chorea. Pract Neurol. 2007; 7 (6): 360-373.
3. Peall KJ, Kurian MA,. Benign hereditary chorea: an update. Tremor Other Hyperkinet Mov (N Y). 2015; 5: 314.
4. Carapito R, Paul N, Untrau M, et al. A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. Mov Disord. 2015; 30 (3): 423-427.
5. Chen YZ, Friedman JR, Chen DH, et al. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol. 2014; 75 (4): 542-549.
6. Mencacci NE, Erro R, Wiethoff S, et al. ADCY5 mutations are another cause of benign hereditary chorea. Neurology. 2015; 85 (1): 80-88.
7. Chen YZ, Matsushita MM, Robertson P, et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol. 2012; 69 (5): 630-635.
8. Fernandez M, Raskind W, Wolff J, et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol. 2001; 49 (4): 486-492.
9. Raskind WH, Matsushita M, Peter B, et al. Familial dyskinesia and facial myokymia (FDFM): Follow-up of a large family and linkage to chromosome 3p21-3q21. Am J Med Genet Part B Neuropsychiatr Genet. 2009; 150 (4): 570-574.
10. Matsuoka I, Suzuki Y, Defer N, et al. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem. 1997; 68 (2): 498-506.
11. Iwamoto T, Okumura S, Iwatsubo K, et al. Motor dysfunction in type 5 adenylyl cyclase-null mice. J Biol Chem. 2003; 278 (19): 16936-16940.
12. Park HY, Kang YM, Kang Y, et al. Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease. J Neurosci. 2014; 34 (35): 11744-11753.
13. Chang FCF, Westenberger A, Dale RC, et al. Phenotypic Insights into ADCY5 -Associated Disease. Movement Disorders. Forthcoming.
14. Lumsden DE, Kaminska M, Gimeno H, et al. Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia. Dev Med Child Neurol. 2013; 55 (6): 567-574.
15. Brüggemann N, Kühn A, Schneider SA, et al. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology. 2015; 84 (9): 895-903.
16. Udupa K, Chen R,. The mechanisms of action of deep brain stimulation and ideas for the future development. Prog Neurobiol. 2015; 133: 27-49.
17. Inagaki H, Ohye T, Suzuki T, et al. Decrease in GTP cyclohydrolase I gene expression caused by inactivation of one allele in hereditary progressive dystonia with marked diurnal fluctuation. Biochem Biophys Res Commun. 1999; 260 (3): 747-751.
18. Furukawa Y,. GTP cyclohydrolase 1-deficient dopa-responsive dystonia. February 21, 2002. March 5, 2015. In: Pagon RA, Adam MP, Ardinger HH, et al.eds. GeneReviews®. Seattle: University of Washington; 1993-2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK263441/.